Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-29 Sale |
2021-04-07 4:08 pm |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
33,750 | $2.4411 | $82,388 | 309,960 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-14 4:18 pm |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
20,000 | $1.0842 | $21,685 | 1,580 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-08 7:11 pm |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
8,731 | $0.94 | $8,207 | 21,580 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-08 7:10 pm |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
10,000 | $0.9 | $9,000 | 32,857 (Direct) |
View |
| 2021-01-06 Sale |
2021-01-06 7:15 pm |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
11,269 | $0.94 | $10,593 | 30,311 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-06 7:15 pm |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
35,000 | $0.9 | $31,500 | 104,789 (Indirect Direct) |
View |
| 2020-12-17 Sale |
2020-12-21 07:00 am |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
25,000 | $0.73 | $18,250 | 41,580 (Direct) |
View |
| 2020-12-04 Sale |
2020-12-08 07:04 am |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
71,519 | $0.83 | $59,361 | 92,091 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-16 4:01 pm |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
10,000 | $0.81 | $8,100 | 66,580 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-05 07:22 am |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
10,000 | $0.72 | $7,200 | 76,580 (Direct) |
View |
| 2020-06-08 Purchase |
2020-06-09 07:27 am |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
5,000 | $0.92 | $4,600 | 281,509 (Direct) |
View |
| 2020-05-29 Purchase |
2020-06-01 06:27 am |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
10,000 | $0.9 | $9,000 | 99,068 (Direct) |
View |
| 2020-05-28 Purchase |
2020-05-29 06:49 am |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
5,000 | $0.9 | $4,500 | 276,509 (Direct) |
View |
| 2020-05-28 Purchase |
2020-05-29 06:48 am |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
10,000 | $0.91 | $9,100 | 89,068 (Direct) |
View |
| 2020-05-27 Purchase |
2020-05-28 06:47 am |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
10,000 | $0.85 | $8,500 | 79,068 (Direct) |
View |
| 2020-05-26 Purchase |
2020-05-27 07:25 am |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
10,000 | $0.82 | $8,200 | 69,068 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-18 Option Award |
2021-06-22 4:12 pm |
N/A 2031-06-18 |
ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance |
75,000 | $0 | 75,000 (Direct) |
View |
Ownership |
2021-06-22 4:02 pm |
N/A 2030-10-27 |
ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance |
0 | $0 | 8,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-04-30 4:22 pm |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
22,815 | $0 | 316,525 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:18 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:16 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:15 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:13 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:11 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:10 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:08 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
50,000 | $0 | 309,960 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:05 pm |
N/A 2031-04-05 |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-03-25 5:01 pm |
2022-01-04 2031-01-04 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-03-25 5:00 pm |
2022-01-04 2031-01-04 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-03-25 5:00 pm |
2022-01-04 2031-01-04 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-03-25 5:00 pm |
2022-01-04 2031-01-04 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-10-22 Option Award |
2020-10-26 5:14 pm |
N/A 2030-10-22 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 08:00 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
100,503 | $0.87 | 382,012 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 08:00 am |
2019-12-10 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
100,503 | $0 | 382,012 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-16 4:06 pm |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
26,000 | $0.87 | 317,962 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-16 4:06 pm |
2019-12-11 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
26,000 | $0 | 317,962 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:23 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
5,000 | $0.87 | 75,299 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:23 am |
2019-12-11 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
5,000 | $0 | 75,299 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:22 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
5,000 | $0.87 | 144,840 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:22 am |
2019-12-11 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
5,000 | $0 | 144,840 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:21 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
2,874 | $0.87 | 165,762 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 08:21 am |
2019-12-11 2024-12-11 |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
2,874 | $0 | 165,762 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:39 am |
2019-12-11 N/A |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
10 | $1,144 | 64,243 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:39 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
11,386 | $0.87 | 64,243 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:38 am |
2019-12-11 N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
9 | $1,144 | 134,789 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:38 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Wells David R. Chief Financial Officer |
10,350 | $0.87 | 134,789 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:37 am |
2019-12-11 N/A |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
44 | $1,144 | 267,710 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:37 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
51,747 | $0.87 | 267,710 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:36 am |
2019-12-11 N/A |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
4 | $1,144 | 160,736 (Direct) |
View |
| 2020-06-08 Conversion |
2020-06-10 07:36 am |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
5,175 | $0.87 | 160,736 (Direct) |
View |